Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Financial Statements Details - Outstanding Securities Considered Anti-Dilutive (Details)

v3.20.2
Condensed Consolidated Financial Statements Details - Outstanding Securities Considered Anti-Dilutive (Details) - shares
shares in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Antidilutive Securities Excluded From Computation Of Earnings Per Share        
Antidilutive securities excluded from computation of net loss per share (in shares) 5,779 8,218 6,323 8,144
Convertible preferred stock.        
Antidilutive Securities Excluded From Computation Of Earnings Per Share        
Antidilutive securities excluded from computation of net loss per share (in shares) 5,196 6,256 5,726 6,256
Common stock options and RSUs        
Antidilutive Securities Excluded From Computation Of Earnings Per Share        
Antidilutive securities excluded from computation of net loss per share (in shares) 564 1,934 578 1,861
Warrants for common stock        
Antidilutive Securities Excluded From Computation Of Earnings Per Share        
Antidilutive securities excluded from computation of net loss per share (in shares) 19 28 19 27